4//SEC Filing
Leonard Reid 4
Accession 0000899243-21-018117
CIK 0001785530other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:31 PM ET
Size
7.8 KB
Accession
0000899243-21-018117
Insider Transaction Report
Form 4
Leonard Reid
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2021-04-30+27,311→ 27,311 totalExercise: $16.00Exp: 2031-04-29→ Common Stock (27,311 underlying) - Award
Stock Option (right to buy)
2020-12-08+99,163→ 99,163 totalExercise: $4.77Exp: 2030-12-07→ Common Stock (99,163 underlying)
Footnotes (2)
- [F1]The option was granted on December 8, 2020. 25% of the shares underlying the options vest on December 8, 2021, the remaining shares vest in equal monthly installments through December 8, 2024.
- [F2]The option was granted on April 30, 2021. The shares underlying the option vest over four years in equal monthly installments through April 30, 2025.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001857795
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 4:31 PM ET
- Size
- 7.8 KB